
SEC exempt reporting adviser · Est. 2012
Lightstone Ventures
Lightstone Ventures is a life-science investor that backs biotech and medtech founders building therapies and devices intended to improve patient care.
Investment activity
Round-by-round activity is part of PRO
Key signal this week
Is Lightstone Ventures right for your round?
Key stats
Fund cycle Public record
Fund vehicles on public registers (SEC adviser filings). Values are the gross assets each filing reports, not fund sizes.
Latest investments
Rounds Lightstone Ventures joined, from press and the firm’s own posts.
Every round Lightstone Ventures joined
Round sizes, Lightstone Ventures’s role and who invested alongside.
Notable portfolio
Portfolio and exits
Every company Lightstone Ventures backed and how the exits played out.
Where the money goes
Share of companies at first investment, from the rounds we track.
Investment team
Where to meet Lightstone Ventures
Events where Lightstone Ventures’s team spoke or showed up, from event programmes, press and the firm’s own posts.
Signals
Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.
Founders also look at
Frequently asked questions
Lightstone Ventures is based in Portola Valley, United States. It also has offices in Boston and Dublin.
In 2012.
6 fund vehicles are on public registers (SEC adviser filings), including LIGHTSTONE VENTURES III, L.P., LIGHTSTONE VENTURES II, L.P. and LIGHTSTONE VENTURES, L.P.
Sectors: Biotech, Medtech, Life sciences. From the firm’s own website.
Lightstone Ventures lists 36 portfolio companies on its website, including 65LAB, Alchemab Therapeutics, Allay Therapeutics, ALX Oncology and Amber Therapeutics.
Firms whose websites list some of the same companies include ARCH Venture Partners, Atlas Venture and Canaan.
Know before Lightstone Ventures’s next round is announced.
PRO tracks Lightstone Ventures’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.